Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6551466 | 0.98 | DNMT1 (0.57) | DNMT1ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL367652 | 0.98 | DNMT1 (0.57) | DNMT1ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL3818647 | 0.98 | DNMT1 (0.57) | DNMT1ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL8705730 | 0.87 | ALDH1A1 (0.59) | DNMT1ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL28785463 | 0.76 | ALDH1A1 (0.41) | DNMT1ALDH1A1KMT2AMEN1L3MBTL1 | |
| SCHEMBL29009430 | 0.76 | CYP2C9 (0.50) | ALDH1A1KMT2AMEN1L3MBTL1HPGD | |
| SCHEMBL3240261 | 0.76 | ALDH1A1 (0.56) | ALDH1A1KMT2AMEN1L3MBTL1HPGD | |
| P-Xylene SCHEMBL27791681 | 0.76 | GAA (0.58) | DNMT1ALDH1A1KMT2AMEN1CYP2C9 | |
| P-Xylene SCHEMBL2456088 | 0.76 | GAA (0.58) | DNMT1ALDH1A1KMT2AMEN1CYP2C9 | |
| SCHEMBL3971967 | 0.76 | ALDH1A1 (0.65) | ALDH1A1KMT2AMEN1L3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102272212-A | Sulfur-containing cycloaliphatic compound, process for its preparation, filled sulfur-vulcanizable elastomer composition containing same and articles fabricated therefrom | — | 2011-12-07 | — | — | CN | claimed |
| US-20020151570-A1 | Thiosulfonic acid S-esters as agents for protecting material | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-17 | — | — | US | claimed |
| EP-0495253-B1 | Method for the photographic production of silver images | AGFA GEVAERT NV (BE) | 1995-05-10 | — | — | EP | claimed |
| US-5266442-A | Method for increasing the contrast of photographic silver images | AGFA-GEVAERT N.V. (BE) | 1993-11-30 | — | — | US | claimed |
| EP-0495253-A1 | Method for the photographic production of silver images | AGFA-GEVAERT N.V. (BE) | 1992-07-22 | — | — | EP | claimed |
| JP-4333841-A | — | — | None | — | — | JP | disclosed |
| US-20230174495-A1 | TRIAZINANES POSSESSING THIOSULFONATE END-GROUPS AND METHODS OF MAKING THEM | FLEXSYS IP HOLDINGS, LLC | 2023-06-08 | — | — | US | disclosed |
| EP-4139285-A1 | TRIAZINANES POSSESSING THIOSULFONATE END-GROUPS AND METHODS OF MAKING THEM | Flexsys America L.P. (US) | 2023-03-01 | — | — | EP | disclosed |
| US-11230525-B2 | Organic sulfur compound, method for preparing same, and pharmaceutical composition for preventing or treating cancer or an inflammatory disease, containing same as active ingredient | SOOKMYUNG WOMENS UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2022-01-25 | — | — | US | disclosed |
| WO-2021216487-A1 | TRIAZINANES POSSESSING THIOSULFONATE END-GROUPS AND METHODS OF MAKING THEM | FLEXSYS AMERICA L.P. (US) | 2021-10-28 | — | — | WO | disclosed |
| US-20210300865-A1 | NOVEL ORGANIC SULFUR COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR AN INFLAMMATORY DISEASE, CONTAINING SAME AS ACTIVE INGREDIENT | SOOKMYUNG WOMENS UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2021-09-30 | — | — | US | disclosed |
| WO-2019143142-A1 | NOVEL PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING GLIOBLASTOMA | 숙명여자대학교 산학협력단 | 2019-07-25 | — | — | WO | disclosed |
| JP-H04333841-A | PHOTOGRAPHIC PRODUCTION OF SILVER IMAGE | AGFA GEVAERT NV | 1992-11-20 | — | — | JP | disclosed |
| EP-0473209-A1 | Method of making direct-positive computer output images | AGFA-GEVAERT N.V. (BE) | 1992-03-04 | — | — | EP | disclosed |
| EP-0462528-A1 | Method for preparing a silver halide emulsion | KONICA CORPORATION (JP) | 1991-12-27 | — | — | EP | disclosed |
| EP-0190375-B1 | SUBSTITUTED TRIAZOLOPYRIMIDINES AND THEIR USE IN LIGHT-SENSITIVE PHOTOGRAPHIC ELEMENTS | AGFA-GEVAERT N.V. (BE) | 1989-04-19 | — | — | EP | disclosed |
| US-4727017-A | ANTIFOGGING AGENTS; STABILIZERS | AGFA-GEVAERT, N.V. (BE) | 1988-02-23 | — | — | US | disclosed |
| EP-0190375-A1 | Substituted triazolopyrimidines and their use in light-sensitive photographic elements | AGFA-GEVAERT N.V. (BE) | 1986-08-13 | — | — | EP | disclosed |
| EP-0129527-A2 | Vulcanisable rubber composition and compounds useful as stabilising agents for rubber vulcanisates | MONSANTO EUROPE S.A./N.V. (BE) | 1984-12-27 | — | — | EP | disclosed |
| US-3977880-A | Direct-positive emulsion containing silver halide grains internally doped with metal ions, surface ripened with gold and sulfur compound and fogged by light exposure | FUJI PHOTO FILM CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174495-A1 | TRIAZINANES POSSESSING THIOSULFONATE END-GROUPS AND METHODS OF MAKING THEM | TST, ARSA, TERT | DNMT1 1734/4885ALDH1A1 174/4885KMT2A 3001/4885 |
| US-11230525-B2 | Organic sulfur compound, method for preparing same, and pharmaceutical composition for preventing or treating cancer or an inflammatory disease, containing same as active ingredient | HDAC1, HDAC2, HDAC11 | DNMT1 517/4885ALDH1A1 532/4885KMT2A 164/4885 |
| US-20020151570-A1 | Thiosulfonic acid S-esters as agents for protecting material | TST, STS, SULT1E1 | DNMT1 4115/4885ALDH1A1 203/4885KMT2A 4531/4885 |
| US-20210300865-A1 | NOVEL ORGANIC SULFUR COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER OR AN INFLAMMATORY DISEASE, CONTAINING SAME AS ACTIVE INGREDIENT | HDAC1, HDAC2, HDAC11 | DNMT1 536/4885ALDH1A1 658/4885KMT2A 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.